EUVIMEDEUVIMED entdecken
Open Access

Transcatheter Palliation With Pulmonary Artery Flow Restrictors in Neonates With Congenital Heart Disease: Feasibility, Outcomes, and Comparison With a Historical Hybrid Stage 1 Cohort

Francesca Sperotto, Nora Lang, Meena Nathan iD, Aditya Kaza iD, David M Hoganson iD, Eleonore Valencia iD, Kirsten Odegard, Catherine K Allan, Eduardo M da Cruz iD, Pedro J Del Nido iD, Sitaram M Emani iD, Christopher Baird und 1 weitere

Circulation: Cardiovascular Interventions · 2023-12 · 16 (12)

DOI: 10.1161/circinterventions.123.013383 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation: Cardiovascular Interventions, 2023-12. Verfasst von Francesca Sperotto und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology (F.S., N.L., E.V., C.K.A., E.M.d.C., N.M.), Boston Children's Hospital, Harvard Medical School, MA. Hauptthemen laut MEDLINE: Hypoplastic Left Heart Syndrome, Heart Defects, Congenital. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Neonates with complex congenital heart disease and pulmonary overcirculation have been historically treated surgically. However, subcohorts may benefit from less invasive procedures. Data on transcatheter palliation are limited. METHODS: We present our experience with pulmonary flow restrictors (PFRs) for palliation of neonates with congenital heart disease, including procedural feasibility, technical details, and outcomes. We then compared our subcohort of high-risk single ventricle neonates palliated with PFRs with a similar historical cohort who underwent a hybrid Stage 1. Cox regression was used to evaluate the association between palliation strategy and 6-month mortality. RESULTS: From 2021 to 2023, 17 patients (median age, 4 days; interquartile range [IQR], 2–8; median weight, 2.5 kilograms [IQR, 2.1–3.3]) underwent a PFR procedure; 15 (88%) had single ventricle physiology; 15 (88%) were high-risk surgical candidates. All procedures were technically successful. At a median follow-up of 6.2 months (IQR, 4.0–10.8), 13 patients (76%) were successfully bridged to surgery (median time since PFR procedure, 2.6 months [IQR, 1.1–4.4]; median weight, 4.9 kilograms [IQR, 3.4–5.8]). Pulmonary arteries grew adequately for age, and devices were easily removed without complications. The all-cause mortality rate before target surgery was 24% (n=4). Compared with the historical hybrid stage 1 cohort (n=23), after adjustment for main confounding (age, weight, intact/severely restrictive atrial septum or left ventricle to coronary fistulae), the PFR procedure was associated with a significantly lower all-cause 6-month mortality risk (adjusted hazard ratio, 0.26 [95% CI, 0.08–0.82]). CONCLUSIONS: Transcatheter palliation with PFR is feasible, safe, and represents an effective strategy for bridging high-risk neonates with congenital heart disease to surgical palliation, complete repair, or transplant while allowing for clinical stabilization and somatic growth.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypoplastic Left Heart SyndromeHeart Defects, CongenitalInfant, NewbornHumansPulmonary ArteryFeasibility StudiesTreatment OutcomeHeart VentriclesRetrospective StudiesPalliative Care

Stichwörter der Autor:innen

cardiac catheterizationheart defects, congenitalstage 1 Norwood procedureuniventricular heart

Autor:innen und Institutionen

  • Department of Cardiology (F.S., N.L., E.V., C.K.A., E.M.d.C., N.M.), Boston Children's Hospital, Harvard Medical School, MA.
  • Department of Pediatric Cardiology, University Heart & Vascular Center Hamburg, Germany (N.L.).
  • Department of Cardiac Surgery (M.N., A.K., D.M.H., P.J.D.N., S.M.E., C.B.), Boston Children's Hospital, Harvard Medical School, MA.
  • Department of Cardiac Anesthesia (K.O.), Boston Children's Hospital, Harvard Medical School, MA.

ORCID-Profile: Meena Nathan, Aditya Kaza, David M Hoganson, Eleonore Valencia, Eduardo M da Cruz, Pedro J Del Nido, Sitaram M Emani, Nicola Maschietto

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Sperotto, F., Lang, N., Nathan, M., Kaza, A., Hoganson, D. M., Valencia, E., Odegard, K., Allan, C. K., da Cruz, E. M., Del Nido, P. J., Emani, S. M., Baird, C., & Maschietto, N. (2023). Transcatheter Palliation With Pulmonary Artery Flow Restrictors in Neonates With Congenital Heart Disease: Feasibility, Outcomes, and Comparison With a Historical Hybrid Stage 1 Cohort. Circulation: Cardiovascular Interventions, 16(12). https://doi.org/10.1161/circinterventions.123.013383

Vancouver

Sperotto F, Lang N, Nathan M, Kaza A, Hoganson DM, Valencia E, et al. Transcatheter Palliation With Pulmonary Artery Flow Restrictors in Neonates With Congenital Heart Disease: Feasibility, Outcomes, and Comparison With a Historical Hybrid Stage 1 Cohort. Circulation: Cardiovascular Interventions. 2023;16(12). doi:10.1161/circinterventions.123.013383

BibTeX
@article{Sperotto2023,
  author = {Sperotto, Francesca and Lang, Nora and Nathan, Meena and Kaza, Aditya and Hoganson, David M and Valencia, Eleonore and Odegard, Kirsten and Allan, Catherine K and da Cruz, Eduardo M and Del Nido, Pedro J and Emani, Sitaram M and Baird, Christopher and Maschietto, Nicola},
  title = {Transcatheter Palliation With Pulmonary Artery Flow Restrictors in Neonates With Congenital Heart Disease: Feasibility, Outcomes, and Comparison With a Historical Hybrid Stage 1 Cohort},
  journal = {Circulation: Cardiovascular Interventions},
  year = {2023},
  volume = {16},
  number = {12},
  doi = {10.1161/circinterventions.123.013383}
}
Kostenlos starten →